Topic:
Biomarkers
Latest Headlines
Latest Headlines
Johns Hopkins: Two genes help predict postpartum depression risk
Johns Hopkins scientists believe two genes could serve as reliable epigenetic biomarkers for postpartum depression.
Biomarker trio enables blood Dx to map heart attack risk
Another team of researchers is tackling the task of developing a blood test designed to predict a patient's likelihood of suffering a heart attack. And they've zeroed on three promising biomarkers to help get the job done.
Fetus secretes hormone that could flag preeclampsia risk
The hormone adrenomedullin is secreted by the fetus during pregnancy and appears to keep pregnant women from developing preeclampsia. And they believe it could become an effective biomarker to help pinpoint patients more likely to develop the dangerous condition.
Mayo Clinic develops drug that stops growth of kidney cancer
An experimental drug designed to block an overactive protein in kidney cancer may provide a more targeted approach to treating the common cancer and could eventually be used as a therapy for other types of the disease.
Dozens of new biomarkers gauge ovarian cancer survival prospects
Scientists at the University of Illinois have used the Cancer Genome Atlas to pinpoint dozens of biomarkers that can gauge a patient's survival prospects with ovarian cancer and also predict when the cancer might return.
Discovery: Thousands of genes mark schizophrenia risk
A global research effort has identified a wide variety of biomarkers that point to the risk of developing schizophrenia. The discovery, led by experts at the Virginia Commonwealth University School of Pharmacy, gives scientists a whole slew of potential new targets for drug treatment.
CV biomarker study finds evidence of bias, exaggeration in the field
Scanning the field of biomarker research for cardiovascular disease, a group of investigators has found some compelling data that suggest the effect of the biomarkers is regularly exaggerated, with signs of bias in the reports. And that clearly could be hurting the medical field's understanding of the biomarkers' significance.
Dutch researchers detect early Parkinson's pathology
European scientists may have discovered the molecular processes involved in the early stages of Parkinson's disease--a clue that could be used to develop new treatments to counteract early Parkinson's cellular changes.
New Scripps tech helps spot autoimmune disease biomarkers
Their initial study involved spotting human blood biomarkers for neuromyelitis optica, an autoimmune disorder that is similar to multiple sclerosis and makes sufferers go blind and become paralyzed.
Protein points to hormone therapy-resistant prostate cancer
Researchers at the Sanford-Burnham Medical Research Institute in La Jolla, CA, have discovered a specific protein that helps prostate cancer cells become resistant to hormone therapy, which could provide a new therapeutic window for improved treatment regimens.
